Monterey Bay Labs Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Monterey Bay Labs General Information

Description

Developer of an epidermal delivery platform intended to offer proprietary InoCyte system for dermatology and skin care. The company's platform commercializes enhancer suspensions that accelerate epidermal delivery, enabling clients to improve compliance with cosmetic products in a range of applications such as anti-aging, whitening, cellulite reduction, acne and hair regrowth.

Contact Information

Formerly Known As
Nanocyte
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 8 HaEshel Street
  • Industrial Park (South)
  • Caesarea 38900
  • Israel
+972
Primary Industry
Drug Delivery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • 8 HaEshel Street
  • Industrial Park (South)
  • Caesarea 38900
  • Israel
+972

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Monterey Bay Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Dec-2017 Completed Out of Business
1. Early Stage VC 01-Feb-2014 Completed Startup
To view Monterey Bay Labs’s complete valuation and funding history, request access »

Monterey Bay Labs Patents

Monterey Bay Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-1956894-A2 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Active 19-Apr-2005
EP-1956894-A4 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Active 19-Apr-2005
EP-1956894-B1 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Inactive 19-Apr-2005
WO-2006111960-A2 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Inactive 19-Apr-2005
WO-2006111960-A3 Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent Inactive 19-Apr-2005 A61K9/0014
To view Monterey Bay Labs’s complete patent history, request access »

Monterey Bay Labs Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Monterey Bay Labs FAQs

  • When was Monterey Bay Labs founded?

    Monterey Bay Labs was founded in 2000.

  • Where is Monterey Bay Labs headquartered?

    Monterey Bay Labs is headquartered in Caesarea, Israel.

  • What is the size of Monterey Bay Labs?

    Monterey Bay Labs has 11 total employees.

  • What industry is Monterey Bay Labs in?

    Monterey Bay Labs’s primary industry is Drug Delivery.

  • Is Monterey Bay Labs a private or public company?

    Monterey Bay Labs is a Private company.

  • What is Monterey Bay Labs’s current revenue?

    The current revenue for Monterey Bay Labs is .

  • How much funding has Monterey Bay Labs raised over time?

    Monterey Bay Labs has raised $9M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process